Exact Mass: 635.1567058

Exact Mass Matches: 635.1567058

Found 15 metabolites which its exact mass value is equals to given mass value 635.1567058, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Aflatoxin B1exo-8,9-epoxide-GSH

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[(4R,5S)-4-hydroxy-11-methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.0²,⁹.0³,⁷.0¹³,¹⁷]nonadeca-1(12),2(9),10,13(17)-tetraen-5-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C27H29N3O13S (635.1421024000001)

This compound belongs to the family of Difurocoumarocyclopentenone Series. These are polycyclic aromatic compounds containing a cyclopenten-2-one ring fused to the coumarin moiety of the difurocoumarin skeleton. Difurocoumarocyclopentenones are a subgroup of the aflatoxins and related compounds

[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl [5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate

C20H27N7O13P2 (635.1142032000001)

Cabozantinib s-malate

Cabozantinib malate (XL184)

C32H30FN3O10 (635.1915132)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor

Cefpiramide sodium

C25H24N8NaO7S2 (635.1107014)

Zosuquidar trihydrochloride

C32H34Cl3F2N3O2 (635.1684538000001)

C1744 - Multidrug Resistance Modulator

Delafloxacin meglumine

C25H29ClF3N5O9 (635.1605810000001)

C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

Tenofovir Disoproxil Fumarate

C23H34N5O14P (635.1839794)

C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

(SR,2R,3S)-2-(O-BOC)-3-(TERT-BUTYLSULFINYL)-3-PHENYLISOSERINEMETHYLESTER

C32H20CuN12 (635.122979)

CO-1686 hydrobromide

C27H29BrF3N7O3 (635.146722)

2,4-Imidazolidinedione, 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethyl-

C29H32F3N5O6S (635.2025288)

8,9-dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1

C27H29N3O13S (635.1421024000001)

D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D000348 - Aflatoxins

2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol di[(2Z)-but-2-enedioate]

C29H34ClN3O9S (635.1704184000001)

Aflatoxin B1exo-8,9-epoxide-GSH

8,9-dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1

C27H29N3O13S (635.1421024000001)

A member of the class of aflatoxins that is 8,9-dihydro-9-hydroxyaflatoxin B1 having an S-glutathionyl moiety attached at position 8. D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D000348 - Aflatoxins

Perphenazine maleate

C21H26ClN3OS. (C4H4O4)2 (635.1704184000001)

(2s)-2-{[(2r,3s,4r)-3,4-dihydroxy-6-{[2-({2-[(1-hydroxyethylidene)amino]ethyl}disulfanyl)ethyl]-c-hydroxycarbonimidoyl}-3,4-dihydro-2h-pyran-2-yl]oxy}-2-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl]ethanimidic acid

(2s)-2-{[(2r,3s,4r)-3,4-dihydroxy-6-{[2-({2-[(1-hydroxyethylidene)amino]ethyl}disulfanyl)ethyl]-c-hydroxycarbonimidoyl}-3,4-dihydro-2h-pyran-2-yl]oxy}-2-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl]ethanimidic acid

C23H33N5O12S2 (635.1567058)